Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 31.53 |
| Low | 31.53 |
| Bid | -- |
| Offer | -- |
| Previous close | 43.40 |
| Average volume | -- |
|---|---|
| Shares outstanding | 96.27m |
| Free float | 94.75m |
| P/E (TTM) | -- |
| Market cap | 224.30m USD |
| EPS (TTM) | -2.51 USD |
Data delayed at least 20 minutes, as of Aug 08 2024 12:30 BST.
More ▼
- Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
- Cabaletta Bio Announces 2026 Strategic Priorities
- Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
- Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
- Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
- Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
- Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
- Cabaletta Bio to Participate in Upcoming Investor Conferences in September
- Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
- Cabaletta Bio Announces Pricing of Public Offering of Securities
More ▼
